The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.
The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...
In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to ...
Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...